Vascular effects of the lercanidipine/enalapril combination: clinical relevance

References

• De Ciuceis C, Salvetti M, Rossini C, et al. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. J Hypertens 2014;32:565-74
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, Boari GE, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003;108:2230-5
   PubMed Web of Science ®Google Scholar
• Izzard AS, Rizzoni D, Agabiti-Rosei E, Heagerty AM. Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens 2005;23:247-50
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Dimitriadis K, Katsiki N, Tousoulis D. Microcirculation in hypertension: an update on clinical significance and therapy. Curr Vasc Pharmacol 2015;13:413-17
   PubMed Web of Science ®Google Scholar
• Feihl F, Liaudet L, Levy BI, Waeber B. Hypertension and microvascular remodelling. Cardiovasc Res 2008;78:274-85
   PubMed Web of Science ®Google Scholar
• Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens 2001;19:1001-6
   PubMed Web of Science ®Google Scholar
• Hartford M, Wendelhag I, Berglund G, et al. Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988;259:2553-7
   PubMed Web of Science ®Google Scholar
• Mathiassen ON, Buus NH, Larsen ML, et al. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 2007;25:1027-34
   PubMed Web of Science ®Google Scholar
• Rizzoni D, Porteri E, De Ciuceis C, et al. Effect of treatment with candesartan or enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. Hypertension 2005;45:659-65
   PubMed Web of Science ®Google Scholar
• Agabiti-Rosei E, Rizzoni D. Regression of small resistance artery structural alterations in hypertension by appropriate antihypertensive treatment. Curr Hypertens Rep 2010;12:80-5
   PubMed Web of Science ®Google Scholar
• Agabiti-Rosei E, Heagarty A, Rizzoni D. Effects of antihypertensive treatment on small artery remodeling. J Hypertens 2009;27:1107-14
   PubMed Web of Science ®Google Scholar
• Burnier M, Vuignier Y, Wuerzner G. State-of-the-art treatment of hypertension: established and new drugs. Eur Heart J 2014;35:557-62
   PubMed Web of Science ®Google Scholar
• Burnier M. Renal protection with calcium antagonists: the role of lercanidipine. Curr Med Res Opin 2013;29:1727-35
   PubMed Web of Science ®Google Scholar
• Cesarone MR, Incandela L, Ledda A, et al. Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension. Angiology 2000;51:S53-S63
   PubMed Web of Science ®Google Scholar
• Duda-Seiman D, Duda-Seiman C, Borcan F, et al. Calcium channel blockers – benefits upon vascular biology in hypertensive patients. Cardiovasc Hematol Agents Med Chem 2015;13:54-62
   PubMedGoogle Scholar
• Papademetriou V, Katsiki N, Doumas M, et al. Halting arterial aging in patients with cardiovascular disease: hypolipidemic and antihypertensive therapy. Curr Pharm Des 2014;20:6339-49
   PubMed Web of Science ®Google Scholar
• Mackenzie IS, McEniery CM, Dhakam Z, et al. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009;54:409-13
   PubMed Web of Science ®Google Scholar
• Borghi C, Cicero AF. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. Clin Drug Investig 2010;30:843-54
   PubMed Web of Science ®Google Scholar
• Tocci G, Palano F, Pagannone E, et al. Fixed combination therapies in hypertension management: focus on enalapril/lercanidipine. Expert Rev Cardiovasc Ther 2009;7:115-23
   PubMedGoogle Scholar
• Ghiadoni L, Bruno RM, Cartoni G, et al. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome. Vascul Pharmacol 2015
   PubMed Web of Science ®Google Scholar
• Derosa G, Bonaventura A, Romano D, et al. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients. J Clin Pharm Ther 2014;39:277-85
   PubMed Web of Science ®Google Scholar
• Derosa G, Bonaventura A, Romano D, et al. Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study. J Am Soc Hypertens 2014;8:422-8
   PubMed Web of Science ®Google Scholar
• Feihl F, Liaudet L, Waeber B. The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep 2009;11:182-9
   PubMed Web of Science ®Google Scholar
• Palombo C, Kozakova M. Arterial stiffness, atherosclerosis and cardiovascular risk: pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol 2016;77:1-7
   PubMed Web of Science ®Google Scholar
• Keymel S, Heinen Y, Balzer J, et al. Characterization of macro-and microvascular function and structure in patients with type 2 diabetes mellitus. Am J Cardiovasc Dis 2011;1:68-75
   PubMedGoogle Scholar
• Kozakova M, Palombo C. Diabetes mellitus, arterial wall, and cardiovascular risk assessment. Int J Environ Res Public Health 2016;13:E201
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;31:1281-357
   Google Scholar
• van den Meiracker AH. A global approach to hypertension. EuroIntervention 2013;9(Suppl R):R16-20
   PubMed Web of Science ®Google Scholar
• Puig JG, Calvo C, Luurila O, et al. Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM. J Hum Hypertens 2007;21:917-24
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, O’Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010;31:1865-71
   PubMed Web of Science ®Google Scholar